EQUITY RESEARCH MEMO

Applied Biomics

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)60/100

Applied Biomics is a US-based proteomics service company founded in 2004 and headquartered in Hayward, California. The company offers a comprehensive suite of proteomics services, including 2D DIGE, mass spectrometry, and host cell protein (HCP) analysis, with a focus on biomarker discovery for research and diagnostic applications. Serving over 5,000 academic and industry customers, Applied Biomics has established itself as a reliable partner in the proteomics space, though it operates as a private entity with limited public financial disclosure. The proteomics services market is growing, driven by increasing demand for biomarker discovery and personalized medicine. Applied Biomics is well-positioned to benefit from this trend, but faces competition from larger players and emerging technologies. As a service provider, its growth depends on expanding its customer base and service offerings. While the company has a strong track record, its lack of recent funding rounds or major partnerships limits visibility. A conviction score of 60 reflects moderate confidence based on established market presence but uncertain near-term growth catalysts.

Upcoming Catalysts (preview)

  • Q3 2026Launch of Novel High-Throughput Proteomics Platform70% success
  • TBDStrategic Partnership with a Top Pharma Company for Biomarker Discovery50% success
  • TBDExpansion into Clinical Diagnostic Services via CLIA Certification40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)